PVMS signs agreement with Arcadian
Wholly-owned subsidiary of Advanzeon Solutions, Pharmacy Value Management Solutions (PVMS), signed an agreement Dec. 18 with Arcadian Telepsychiatry. Read More »
Wholly-owned subsidiary of Advanzeon Solutions, Pharmacy Value Management Solutions (PVMS), signed an agreement Dec. 18 with Arcadian Telepsychiatry. Read More »
In the next eight years, pharmacists’ employment is only expected to grow 3 percent in the United States, according to the Bureau of Labor Statistics. Read More »
The Fenix Continence Restoration System was approved by the U.S. Food and Drug Administration Dec. 18. Read More »
The Squarekids subcutaneous injection syringe was launched by Daiichi Sankyo, Japan Vaccine Company and Sanofi K.K. Dec. 9. Read More »
The Utilization Review Accreditation Commission (URAC) granted Diplomat Pharmacy full specialty pharmacy reaccreditation Dec. 17. Read More »
Kimberly Bartholomew was recently named the new GRx Hawaii regional account executive by Guaranteed Returns. Read More »
AlliancePharma Inc. launched Elitex, the first virtual schedule manager of its kind to be designed specifically for pharmacies, Wednesday. Read More »
In response to the U.S. Senate Special Committee on Aging's hearing on "Sudden Price Spikes in Off-Patent Prescription Drugs" held earlier this month, Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt asked policymakers to take an initiative toward making generic drugs easier to produce and distribute. Read More »
Recent laboratory analysis conducted by the Food and Drug Administration (FDA) confirms that the herbal weight loss dietary supplement La’Trim Plus contains undeclared controlled substance sibutramine and chemical phenolphthalein. Read More »
Galapagos NV and Gilead Sciences Inc. entered into an international coalition Dec. 17 to develop and commercialize the JAK1-selective inhibitor filgotinib for inflammatory disease indications. Read More »
New Hampshire’s Department of Health and Human Services (DHHS) and Rite Aid signed a standing order Monday to stock naloxone, an emergency treatment drug for opiate overdoses. Read More »
While the Biosimilars Council, a division of the Generic Pharmaceutical Association (GPhA), applauds the Food and Drug Administration's (FDA) current discussions on the next Biosimilar User Fee Act (BsUFA), it hopes to collaborate even more with the FDA on biosimilar medications. Read More »
The Food and Drug Administration (FDA) granted approval Monday for Uptravi, a new oral IP prostacyclin receptor agonist medication to treat adults with pulmonary arterial hypertension (PAH). Read More »
The International Pharmaceutical Federation (FIP) published a guide Dec. 16, highlighting the significant role pharmacists can play in reducing tobacco use. Read More »
Cigna-HealthSpring is expanding its partnership with Jefferson Health to provide Tri-state area residents with more affordable access to top doctors and better care. Read More »
In moving forward with its plan to purchase Rite Aid, Walgreens Boots Alliance said Monday it has finished the placement of $12.8 billion term loan and bridge facilities. Read More »
The Academy of Managed Care Pharmacy (AMCP) named Susan Cantrell its new CEO Friday. Read More »
Prime Therapeutics selected Scott Fries, its senior vice president of Government Programs, as the company's chief operating officer. Read More »
CVS Health finalized its purchase of Target's pharmacy and clinic business Thursday. Read More »
AstraZeneca said Thursday it has completed its agreement to purchase ZS Pharma. Read More »